Development of UKY-21, a Novel VMAT2 Inhibitor for the Treatment of Methamphetamine Use Disorder

Grants and Contracts Details

StatusFinished
Effective start/end date1/1/22 → 6/30/23

Funding

  • University of Kentucky Substance Use Priority Research Area: $50,000.00